Response to "Postoperative Myocardial Injury and Outcomes in Liver and Kidney Transplant Patients"

Affiliations

¹ Univ. Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, 38000 Grenoble, France. Electronic address: maferjani@chu-grenoble.fr.
² Univ. Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, 38000 Grenoble, France.
³ Univ. Grenoble Alpes, Department of Cardiology, CHU Grenoble Alpes, 38000 Grenoble, France.
⁴ Univ. Grenoble Alpes, Department of Hepatology and Gastroenterology, CHU Grenoble Alpes, 38000 Grenoble, France.

Comment

Malik Ferjani et al. Cardiovasc Revasc Med. 2023 Jan.

. 2023 Jan:46:119-120.

doi: 10.1016/j.carrev.2022.08.017. Epub 2022 Aug 18.

¹ Univ. Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, 38000 Grenoble, France. Electronic address: maferjani@chu-grenoble.fr.
² Univ. Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, 38000 Grenoble, France.
³ Univ. Grenoble Alpes, Department of Cardiology, CHU Grenoble Alpes, 38000 Grenoble, France.
⁴ Univ. Grenoble Alpes, Department of Hepatology and Gastroenterology, CHU Grenoble Alpes, 38000 Grenoble, France.

No abstract available

Conflict of interest statement

Declaration of competing interest Authors declare no Conflict of Interests for this article.

Reply to the Letter to the Editor: Response to "Postoperative Myocardial Injury and Outcomes in Liver and Kidney Transplant Patients".
Yang M, Ben-Dor I. Yang M, et al. Cardiovasc Revasc Med. 2023 Jan;46:121. doi: 10.1016/j.carrev.2022.09.017. Epub 2022 Sep 29. Cardiovasc Revasc Med. 2023. PMID: 36207274 No abstract available.

Postoperative Myocardial Injury and Outcomes in Liver and Kidney Transplant Patients.
Yang M, Qamer SZ, Hill AP, Case BC, Gilbert AJ, Satoskar RS, Lalos AT, Valdiviezo C, Rogers T, Satler LF, Waksman R, Ben-Dor I. Yang M, et al. Cardiovasc Revasc Med. 2022 Aug;41:154-158. doi: 10.1016/j.carrev.2022.03.012. Epub 2022 Mar 15. Cardiovasc Revasc Med. 2022. PMID: 35304096